NCT03986606View on ClinicalTrials.gov

A Study of PSB205 in Subjects With Advanced Solid Tumors

PHASE1UnknownINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

July 5, 2019

Primary Completion Date

February 28, 2021

Study Completion Date

July 28, 2021

Conditions
Neoplasm Malignant
Interventions
BIOLOGICAL

PSB205

PSB205 is a bi-functional product that has been engineered to contain two unique monoclonal antibodies.

Trial Locations (1)

78229

RECRUITING

Next Oncology, San Antonio

Sponsors
All Listed Sponsors
collaborator

Pharmaceutical Research Associates

OTHER

lead

Qilu Puget Sound Biotherapeutics (dba Sound Biologics)

INDUSTRY